type here...

CATEGORIES

Treatments

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

Medika Life -
Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Medika Life -
Walgreens today announced the launch of its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research.

Oxycodone No Better in Treating Post-Orthopedic Surgical Pain

Dr. Hesham A. Hassaballa -
The opioid crisis has taken the lives of thousands of people in our country. In fact, according to the CDC, opioid overdose deaths hit...

Is mRNA Technology the New Penicillin?

Robert Turner, Founding Editor -
mRNA medicines are sets of instructions and these instructions direct cells in the body to make proteins to prevent or fight disease. The m stands for messenger and RNA is ribonucleic acid, a part of our DNA

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories